Unit Dose Manufacturing Market Report 2026

Unit Dose Manufacturing Market Overview

• Unit Dose Manufacturing market size has reached to $39.37 billion in 2025 • Expected to grow to $106.79 billion in 2030 at a compound annual growth rate (CAGR) of 22.3% • Growth Driver: Increased Healthcare Spending Fuels Growth In The Unit Dose Manufacturing Market • Market Trend: Strategic Partnership Boosts Unit Dose Manufacturing Market • North America was the largest region in 2025.

What Is Covered Under Unit Dose Manufacturing Market?

Unit dosage manufacturing refers to creating individual pre-packaged doses of drugs or other products that hold a drug quantity intended for single-dose administration, usually in an easy-to-use form like tablets, capsules, or vials, for patient dispensing. The main products of unit dose manufacturing are liquid unit dose, solid unit dose, and others. A liquid unit dose refers to a specific and customized amount of liquid medication or chemical enclosed in a single packaging unit, often for single-use delivery. The sourcing includes in-house and outsourcing used by independent pharmacies, long-term care facilities, hospitals, and others.

What Is The Unit Dose Manufacturing Market Growth Forecast?

The unit dose manufacturing market size is expected to see exponential growth in the next few years. It will grow to $106.79 billion in 2030 at a compound annual growth rate (CAGR) of 22.3%. The growth in the forecast period can be attributed to growth in personalized medicine, increased outsourcing of unit dose manufacturing, expansion of home healthcare services, rising regulatory focus on medication safety, innovations in sustainable and biodegradable packaging. Major trends in the forecast period include personalized dosage packaging, automation in drug filling and packaging, smart inventory management, regulatory compliance and serialization, eco-friendly packaging solutions.

Global Unit Dose Manufacturing Market Segmentation

1) By Product: Liquid Unit Dose, Solid Unit Dose, Other Products 2) By Sourcing: In-House, Outsourcing 3) By End-User: Independent Pharmacies, Long Term Care Facility, Hospitals, Other End-Users Subsegments: 1) By Liquid Unit Dose: Liquid Vials, Ampoules, Pre-filled Syringes 2) By Solid Unit Dose: Tablets, Capsules, Powder Packs 3) By Other Products: Transdermal Patches, Inhalation Doses, Creams And Ointments In Unit Dose Packaging

What Is The Driver Of The Unit Dose Manufacturing Market?

The rise in healthcare spending is expected to propel the growth of the unit dose manufacturing market going forward. Health spending refers to all costs associated with providing health services, family planning activities, nutrition programs, and emergency help focusing on health. Increasing healthcare expenditure would help advance and develop various health-related services, including unit dose manufacturing, which will support the growth of the unit dose manufacturing market. For instance, in September 2024, according to the statistics published by Cross River Therapy, a US-based provider of ABA therapy services, the U.S. pharmaceutical industry generated $550 billion in revenue, with Americans spending $576.9 billion on medicine, and projected spending is expected to increase to $605-$635 billion by 2025. Therefore, the rise in healthcare spending is driving the growth of the unit dose manufacturing industry.

Key Players In The Global Unit Dose Manufacturing Market

Major companies operating in the unit dose manufacturing market are Nipro Corporation, Catalent Inc., Corden Pharma GmbH, LTS Lohmann Therapie-Systeme AG, PCI Pharma Services, Comar LLC, Renaissance Lakewood LLC, Mikart LLC, Tapemark Company Inc., Bilcare Research, Medical Packaging Inc, American Health Packaging, Aphena Pharma Solutions, Vetter Pharma International GmbH, Baxter International Inc., Fresenius Kabi AG, Patheon Inc., Recipharm AB, Lonza Group AG, Aenova Group, Piramal Pharma Solutions, Jubilant HollisterStier Inc., IDT Biologika GmbH, Famar HealthCare, Vion Pharmaceuticals

Global Unit Dose Manufacturing Market Trends and Insights

Major companies operating in the unit dose manufacturing market are focusing on strategic partnerships to sustain their position in the market. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in November 2023, iA, a US-based provider of integrated pharmacy fulfillment platforms, announced a distributor agreement with Euclid Medical Products, a US-based specialist in multi-unit automated packaging and barcoding systems. Under this partnership, iA's NEXiA Enterprise Software Suite will integrate Euclid’s Axial Adherence Packaging Technology into centralized fulfillment solutions. This collaboration expands the capabilities of iA's centralized fulfillment solutions, providing options for multiple medication dispensing methods, including multi- and unit-dose automated packaging.

What Are Latest Mergers And Acquisitions In The Unit Dose Manufacturing Market?

In February 2025, Jabil Inc., a US-based manufacturing company, acquired Pharmaceutics International, Inc. (Pii) for $307 million. With this acquisition, Jabil aims to expand its pharmaceutical solutions business by integrating development and manufacturing services, thereby delivering end-to-end drug development, clinical, and commercial production capabilities. Pii is a US-based contract development and manufacturing organization (CDMO) specializing in early-stage, clinical, and commercial volume aseptic filling, lyophilization, and oral solid dose manufacturing.

Regional Insights

North America was the largest region in the unit dose manufacturing market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Unit Dose Manufacturing Market?

The unit dose manufacturing market consists of sales of sachets, small bottles, tubes, and pods. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Unit Dose Manufacturing Market Report 2026?

The unit dose manufacturing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the unit dose manufacturing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.